阿里拉姆製藥 ALNY 深 滬
已收盤 08-07 16:00:00 美东时间
219.20
+3.080
+1.43%
華盛通- 最 高219.64
- 今 開217.31
- 成交量 173.60万股
- 最 低 210.49
- 昨 收 216.12
- 總市值 293.31亿
- 52周最高 495.55
- 市盈率 靜 94.10
- 換手率 0.00%
- 52周最低 197.81
- 委 比 -71.60%
- 總股本 1.34亿
- 歷史最高 495.55
- 量 比 0.54
- 振 幅 4.23%
- 歷史最低 5.879
- 每 手 1
- 風險率 72.73%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 潜在涨幅3586.64%！HC Wainwright上调Enlivex目标价至80美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Enlivex"买入"评级，目标价从20美元升至80美元；Canaccord Genuity：维持Pharming Group NV Sponsored ADR"买入"评级，目标价从37美元升至38美元
08-04 11:45
Nasdaq pops 2% as risk appetite roars back
Wall Street opened the trading week on a strong note, with major indexes advancing as investors rotated into technology shares. The Nasdaq Composite (COMP:IND) led the advance, climbing 2.3%, while th...
08-04 02:20
Codexis Appoints David Butler, PhD, to Strategic Advisory Board
Codexis, Inc. has appointed David Butler, PhD, to its Strategic Advisory Board (SAB), bringing over 20 years of experience in oligonucleotide therapeutics, including siRNA and mRNA-based technologies. Butler, previously CTO at Hongene Biotech and with roles at Wave Life Sciences and Alnylam, will support Codexis' growth in enzymatic manufacturing. Carole Cobb is stepping down from the SAB after significant contributions. Codexis leverages its Cod...
08-03 13:00
Microsoft, Amazon among Nasdaq's weekly gainers after bumper earnings
The Nasdaq Composite Index (COMP:IND) closed 1% higher on Friday, led by gains in Amazon (AMZN) after the e-commerce giant reported strong quarterly results. On Thursday, the index closed 2.78% higher...
08-01 04:22
Stifel下调Alnylam目标价至318美元，维持买入评级
投资机构Stifel近日更新了对生物制药公司Alnylam Pharmaceuticals的评级，将其目标股价从444美元下调至318美元，同时维持买入评级...
07-31 22:55
Stifel下调Alnylam目标价至318美元，维持买入评级
投资机构Stifel近日更新了对生物制药公司Alnylam Pharmaceuticals的评级，将其目标股价从444美元下调至318美元，同时维持买入评级...
07-31 22:55
美股大行评级 | 绩后重锤！Meta惨遭16家大行下调目标价；高通、Arm、泛林集团、波士顿科学也遭多家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持TOMI Environmental Solutions"买入"评级，目标价从3.5美元升至7美元；Canaccord Genuity：维持Viking Therapeutics"买入"评级，目标价从107美元升至114美元
07-31 11:43
Cytokinetics wins U.K. nod, NICE endorsement for heart drug
Cytokinetics (CYTK) announced on Thursday that the U.K. drug regulator approved its heart disease medication, Myqorzo (aficamten), and concurrently, the country’s health spending watchdog, the Nationa...
07-30 20:50
